drugset

drugset / Trial / NCT00141401

Safety and Efficacy of Pregabalin in Patients With Diabetic Peripheral Neuropathy.

NCT00141401 ↗

Phase 3 Completed 240 enrolled Pfizer

Non-randomizedSingle-groupOpen-labelTreatment

Summary

To evaluate long-term efficacy and safety of pregabalin in patients with diabetic peripheral neuropathy.

Timeline

Start: 1999-09
Primary completion: —
Completion: 2005-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Pregabalin	Small molecule	—	—

Indications